Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (9989.HK) HKSE

5.38

+0.01(+0.19%)

Updated at January 14 01:01PM

Currency In HKD

Valuation

Market Cap5.46B
Enterprise Value6.75B
P/E Ratio43.23
PEG Ratio12.1
Price/Sales Ratio2.87
Price/Book Ratio1.47
Enterprise/Revenue3.1
Enterprise/EBITDA19.68

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin0.08
Operating Margin-0.05

Management Effectiveness

Return On Assets0.02
Return On Equity0.03

Income Statement

Revenue5.28B
Revenue/Share3.67
Gross Profit1.76B
EBITDA1.2B
Net Income646.74M
Diluted EPS0.44

Balance Sheet

Total Cash3.37B
Total Cash/Share2.1
Total Debt3.37B
Total Debt/Equity0.25
Current Ratio2.39
Book Value Per Share8.47

Price History

52-Week Change49.03
52-Week High7.26
52-Week Low3.6
Moving Average 50 Days5.35
Moving Average 200 Days5.42

Statistics

Average Volume892,499
Shares Outstanding3.27B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.25
Trailing Annual Dividend Yield2.02
Payout Ratio0.17
Last Split FactorN/A
Last Split DateN/A